JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Different Stat5 mediated survival mechanisms, depending on the presence of nuclear and cytoplasmic Stat5 are active in Bcr-Abl transformed CML and in Jak2(V617F) transformed AML cells.